Allogene, broadening its reach, helps start a new biotech in China

Allogene, broadening its reach, helps start a new biotech in China

Source: 
BioPharma Dive
snippet: 

Allogene Therapeutics has started a joint venture with Overland Pharmaceuticals, a newly formed Chinese biotech, to bring allogeneic, or "off the shelf," cell therapies to greater China and other Asian countries.